Clinical Trials Insight: 700022221
Phase of Trial: Phase III
Latest Information Update: 13 Aug 2010
At a glance
- Drugs Ulipristal (Primary)
- Indications Pregnancy
- Focus Registrational; Therapeutic Use
- Sponsors HRA Pharma
- 13 Aug 2010 According to a company media release, Watson Pharmaceuticals plans to launch Ella [ulipristal] as an emergency contraceptive in the fourth quater of 2010.
- 13 Aug 2010 According to an HRA Pharma media release, the US FDA has granted approval for ulipristal as a prescription-only emergency contraceptive, based on results of this and another phase III trial (CTP 700019630).
- 04 Apr 2007 The expected completion date for this trial is now 31 Dec 2007.